Profound Medical Corp 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 2.49, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Profound Medical in Mar 31 2026 quarter, has decreased to 147 days, compared to 151 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 362 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2356, from overall ranking in the fourth quarter 2025 at 2385.

What is Receivable Turnover Ratio?
What is Profound Medical Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PROF Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	56.31 %	-1.02 %	11.74 %	-	-
Y / Y Revenue Change	103.62 %	43.13 %	86.76 %	-0.99 %	82.14 %
Receivable Turnover Ratio (TTM)	2.49	2.41	2.13	1.82	2.27
PROF's Total Ranking	# 2356	# 2385	# 2215	# 2012	# 0
Accounts Receivable average collection period days	147	152	171	200	161
Seq. Receivable Change	31.85 %	-12.06 %	63.6 %	-17.6 %	-16.51 %
Seq. Revenue Change	-10.71 %	13.01 %	139.21 %	-15.64 %	-37.24 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 138
Healthcare Sector	# 363
Overall Market	# 2356

Receivable Turnover Ratio Statistics
High	Average	Low
0.4	0.31	0.16
(Jun 30 2025)		(Dec 31 2023)

PROF Company Profile • Back to PROF Efficiency Comparisons • Compare PROF Receivables Turnover Ratio to its Competitors

Financial Statements
Profound Medical 's Accounts Receivable	$ 10 Millions	Visit PROF's Balance sheet
Profound Medical 's Sales TTM	$ 19 Millions	Visit PROF's Income Statement
Sources of PROF's Revenues		Visit PROF's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PROF's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PROF's Growth Rates	PROF's Roa	PROF's Inventory Turnover Ratio	PROF's Dividend Comparisons
PROF's Profitability Ratios	PROF's Roi	PROF's Asset Turnover Ratio	PROF's Dividend Growth
PROF's Valuation Ratios	PROF's Roe	PROF's Financial Strength Ratios	PROF's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Alnylam Pharmaceuticals Inc	5.37	$ 4,286.923 Millions	$ 798.351 Millions
Karyopharm Therapeutics Inc	5.29	$ 151.118 Millions	$ 28.586 Millions
The Cooper Companies Inc	5.23	$ 4,230.400 Millions	$ 809.400 Millions
Exagen Inc	5.22	$ 67.881 Millions	$ 12.998 Millions
West Pharmaceutical Services Inc	5.22	$ 3,220.500 Millions	$ 616.850 Millions
Cryoport inc	5.20	$ 182.935 Millions	$ 35.172 Millions
Ultragenyx Pharmaceutical Inc	5.19	$ 669.708 Millions	$ 129.002 Millions
Rxsight Inc	5.19	$ 127.178 Millions	$ 24.509 Millions
Kymera Therapeutics Inc	5.15	$ 51.476 Millions	$ 10.000 Millions
Staar Surgical Co	5.14	$ 290.375 Millions	$ 56.445 Millions
Enovis Corp	5.14	$ 2,275.853 Millions	$ 443.115 Millions
Progyny Inc	5.13	$ 1,292.760 Millions	$ 252.064 Millions
Sangamo Therapeutics Inc	5.12	$ 34.557 Millions	$ 6.744 Millions
Sarepta Therapeutics Inc	5.09	$ 2,184.184 Millions	$ 429.021 Millions
Quanterix Corporation	5.09	$ 144.110 Millions	$ 28.332 Millions
Verrica Pharmaceuticals Inc	5.09	$ 37.161 Millions	$ 7.306 Millions
Ligand Pharmaceuticals Incorporated	5.08	$ 274.476 Millions	$ 54.014 Millions
Invivyd Inc	5.07	$ 55.866 Millions	$ 11.029 Millions
Zimmer Biomet Holdings Inc	5.06	$ 8,409.100 Millions	$ 1,660.650 Millions
Anteris Technologies Global Corp	5.06	$ 1.851 Millions	$ 0.366 Millions
Amgen Inc	5.06	$ 45,369.000 Millions	$ 8,974.750 Millions
Amphastar Pharmaceuticals Inc	5.05	$ 720.530 Millions	$ 142.800 Millions
Protagonist Therapeutics inc	5.03	$ 74.063 Millions	$ 14.721 Millions
Pacific Biosciences Of California Inc	5.01	$ 159.992 Millions	$ 31.918 Millions
Pfizer Inc	4.99	$ 63,315.000 Millions	$ 12,699.250 Millions
Abbvie Inc	4.98	$ 62,819.000 Millions	$ 12,618.500 Millions
Carlsmed Inc	4.96	$ 55.386 Millions	$ 11.159 Millions
Repligen Corp	4.96	$ 763.339 Millions	$ 154.015 Millions
Xtant Medical Holdings Inc	4.94	$ 121.001 Millions	$ 24.478 Millions
Agilent Technologies inc	4.94	$ 7,232.000 Millions	$ 1,463.500 Millions

Date modified: 2026-07-07T13:15:25+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.